Home >> Research Area >>PI3K/Akt/mTOR Signaling>>PI3K>> IPI-145 (INK1197)

IPI-145 (INK1197)

PI3K-δ/PI3K-γ inhibitor CAS# 1201438-56-3

IPI-145 (INK1197)

Catalog No. BCC1104----Order now to get a substantial discount!

Product Name & Size Price Stock
IPI-145 (INK1197): 5mg $92 In Stock
IPI-145 (INK1197): 10mg Please Inquire In Stock
IPI-145 (INK1197): 20mg Please Inquire Please Inquire
IPI-145 (INK1197): 50mg Please Inquire Please Inquire
IPI-145 (INK1197): 100mg Please Inquire Please Inquire
IPI-145 (INK1197): 200mg Please Inquire Please Inquire
IPI-145 (INK1197): 500mg Please Inquire Please Inquire
IPI-145 (INK1197): 1000mg Please Inquire Please Inquire
Related Products
  • IC-87114

    Catalog No.:BCC1161
    CAS No.:371242-69-2
  • PI-103

    Catalog No.:BCC1162
    CAS No.:371935-74-9
  • PIK-75

    Catalog No.:BCC1163
    CAS No.:372196-77-5
  • TGX-221

    Catalog No.:BCC1244
    CAS No.:663619-89-4
  • TG100-115

    Catalog No.:BCC1247
    CAS No.:677297-51-7

Quality Control of IPI-145 (INK1197)

Number of papers citing our products

Chemical structure

IPI-145 (INK1197)

3D structure

Chemical Properties of IPI-145 (INK1197)

Cas No. 1201438-56-3 SDF Download SDF
PubChem ID 50905713 Appearance Powder
Formula C22H17ClN6O M.Wt 416.86
Type of Compound N/A Storage Desiccate at -20°C
Synonyms IPI-145; INK1197
Solubility Soluble in DMSO > 10 mM
Chemical Name 8-chloro-2-phenyl-3-[(1S)-1-(7H-purin-6-ylamino)ethyl]isoquinolin-1-one
SMILES CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5
Standard InChIKey SJVQHLPISAIATJ-ZDUSSCGKSA-N
Standard InChI InChI=1S/C22H17ClN6O/c1-13(28-21-19-20(25-11-24-19)26-12-27-21)17-10-14-6-5-9-16(23)18(14)22(30)29(17)15-7-3-2-4-8-15/h2-13H,1H3,(H2,24,25,26,27,28)/t13-/m0/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of IPI-145 (INK1197)

DescriptionIPI-145 is an orally bioavailable and highly selective inhibitor of PI3K-δ and PI3K-γ with IC50 values of 0.36 nM and 19.6 nM, respectively.
TargetsPI3K-δPI3K-γ    
IC500.36 nM19.6 nM    

IPI-145 (INK1197) Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

IPI-145 (INK1197) Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of IPI-145 (INK1197)

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.3989 mL 11.9944 mL 23.9889 mL 47.9777 mL 59.9722 mL
5 mM 0.4798 mL 2.3989 mL 4.7978 mL 9.5955 mL 11.9944 mL
10 mM 0.2399 mL 1.1994 mL 2.3989 mL 4.7978 mL 5.9972 mL
50 mM 0.048 mL 0.2399 mL 0.4798 mL 0.9596 mL 1.1994 mL
100 mM 0.024 mL 0.1199 mL 0.2399 mL 0.4798 mL 0.5997 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on IPI-145 (INK1197)

IPI-145 (also known as INK1197), an isoquinolinone derivative, is a small-molecule phosphoinositide-3 kinases (PI3K) inhibitor that selectively and potently inhibits two PI3K isoforms, PI3K-δ and PI3K-γ, with half maximal inhibition concentration IC50 of 2.5 nM and 27 nM respectively. Despite of preference for PI3K-δ and PI3K-γ, IPI-145 also inhibits other PI3K isoforms, PI3K-α and PI3K-β, to a lesser extent with IC50 of 1602 nM and 85 nM respectively.

Due to the essential role of PI3K-δ in the proliferation of B cell and T cell, IPI-145 exhibits potent anti-proliferative activity against both cells with IC50 of 0.5 nM and 9.5 nM respectively leading to inhibition of neutrophil migration and basophil activation.

Inhibition of immune function through IPI-145-induced PI3K-δ and PI3K-γ blockade potentiates its application in the treatment of multiple inflammatory, autoimmune and hematologic diseases.

References:
[1] Winkler DG1, Faia KL, DiNitto JP, Ali JA, White KF, Brophy EE, Pink MM, Proctor JL, Lussier J, Martin CM, Hoyt JG, Tillotson B, Murphy EL, Lim AR, Thomas BD, Macdougall JR, Ren P, Liu Y, Li LS, Jessen KA, Fritz CC, Dunbar JL, Porter JR, Rommel C, Palombella VJ, Changelian PS, Kutok JL. PI3K-δ and PI3K-γ inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models. Chem Biol. 2013 Nov 21;20(11):1364-74. doi: 10.1016/j.chembiol.2013.09.017. Epub 2013 Nov 7.

Featured Products
New Products
 

Description

Duvelisib is a selectivite p100δ inhibitor with

Keywords:

IPI-145 (INK1197),1201438-56-3,IPI-145; INK1197,Natural Products,PI3K, buy IPI-145 (INK1197) , IPI-145 (INK1197) supplier , purchase IPI-145 (INK1197) , IPI-145 (INK1197) cost , IPI-145 (INK1197) manufacturer , order IPI-145 (INK1197) , high purity IPI-145 (INK1197)

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: